Product Details for NDA 022272
OXYCONTIN (OXYCODONE HYDROCHLORIDE)
10MG
Marketing Status: Prescription
15MG
Marketing Status: Prescription
20MG
Marketing Status: Prescription
30MG
Marketing Status: Prescription
40MG
Marketing Status: Prescription
60MG
Marketing Status: Prescription
80MG
Marketing Status: Prescription
10MG
Marketing Status: Prescription
Active Ingredient: OXYCODONE HYDROCHLORIDE
Proprietary Name: OXYCONTIN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 10MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N022272
Product Number: 001
Approval Date: Apr 5, 2010
Applicant Holder Full Name: PURDUE PHARMA LP
Marketing Status: Prescription
Patent and Exclusivity Information
OXYCONTIN (OXYCODONE HYDROCHLORIDE)
Proprietary Name: OXYCONTIN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 10MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N022272
Product Number: 001
Approval Date: Apr 5, 2010
Applicant Holder Full Name: PURDUE PHARMA LP
Marketing Status: Prescription
Patent and Exclusivity Information
15MG
Marketing Status: Prescription
Active Ingredient: OXYCODONE HYDROCHLORIDE
Proprietary Name: OXYCONTIN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 15MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N022272
Product Number: 002
Approval Date: Apr 5, 2010
Applicant Holder Full Name: PURDUE PHARMA LP
Marketing Status: Prescription
Patent and Exclusivity Information
OXYCONTIN (OXYCODONE HYDROCHLORIDE)
Proprietary Name: OXYCONTIN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 15MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N022272
Product Number: 002
Approval Date: Apr 5, 2010
Applicant Holder Full Name: PURDUE PHARMA LP
Marketing Status: Prescription
Patent and Exclusivity Information
20MG
Marketing Status: Prescription
Active Ingredient: OXYCODONE HYDROCHLORIDE
Proprietary Name: OXYCONTIN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 20MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N022272
Product Number: 003
Approval Date: Apr 5, 2010
Applicant Holder Full Name: PURDUE PHARMA LP
Marketing Status: Prescription
Patent and Exclusivity Information
OXYCONTIN (OXYCODONE HYDROCHLORIDE)
Proprietary Name: OXYCONTIN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 20MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N022272
Product Number: 003
Approval Date: Apr 5, 2010
Applicant Holder Full Name: PURDUE PHARMA LP
Marketing Status: Prescription
Patent and Exclusivity Information
30MG
Marketing Status: Prescription
Active Ingredient: OXYCODONE HYDROCHLORIDE
Proprietary Name: OXYCONTIN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 30MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N022272
Product Number: 004
Approval Date: Apr 5, 2010
Applicant Holder Full Name: PURDUE PHARMA LP
Marketing Status: Prescription
Patent and Exclusivity Information
OXYCONTIN (OXYCODONE HYDROCHLORIDE)
Proprietary Name: OXYCONTIN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 30MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N022272
Product Number: 004
Approval Date: Apr 5, 2010
Applicant Holder Full Name: PURDUE PHARMA LP
Marketing Status: Prescription
Patent and Exclusivity Information
40MG
Marketing Status: Prescription
Active Ingredient: OXYCODONE HYDROCHLORIDE
Proprietary Name: OXYCONTIN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 40MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N022272
Product Number: 005
Approval Date: Apr 5, 2010
Applicant Holder Full Name: PURDUE PHARMA LP
Marketing Status: Prescription
Patent and Exclusivity Information
OXYCONTIN (OXYCODONE HYDROCHLORIDE)
Proprietary Name: OXYCONTIN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 40MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N022272
Product Number: 005
Approval Date: Apr 5, 2010
Applicant Holder Full Name: PURDUE PHARMA LP
Marketing Status: Prescription
Patent and Exclusivity Information
60MG
Marketing Status: Prescription
Active Ingredient: OXYCODONE HYDROCHLORIDE
Proprietary Name: OXYCONTIN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 60MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N022272
Product Number: 006
Approval Date: Apr 5, 2010
Applicant Holder Full Name: PURDUE PHARMA LP
Marketing Status: Prescription
Patent and Exclusivity Information
OXYCONTIN (OXYCODONE HYDROCHLORIDE)
Proprietary Name: OXYCONTIN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 60MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N022272
Product Number: 006
Approval Date: Apr 5, 2010
Applicant Holder Full Name: PURDUE PHARMA LP
Marketing Status: Prescription
Patent and Exclusivity Information
80MG
Marketing Status: Prescription
Active Ingredient: OXYCODONE HYDROCHLORIDE
Proprietary Name: OXYCONTIN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 80MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N022272
Product Number: 007
Approval Date: Apr 5, 2010
Applicant Holder Full Name: PURDUE PHARMA LP
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: OXYCONTIN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 80MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N022272
Product Number: 007
Approval Date: Apr 5, 2010
Applicant Holder Full Name: PURDUE PHARMA LP
Marketing Status: Prescription
Patent and Exclusivity Information